Laura Smalley will be presenting on “Resolving Patent Infringement Issues for Biosimilars Interchangeable Biologics” on the panel entitled “Regulatory and IP Issues for Immunotherapies including Car-T and Antibody Technologies (Don’t Put the “Car-T” Before the Horse).”